412 related articles for article (PubMed ID: 25582460)
1. Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.
Chintagari NR; Nguyen J; Belcher JD; Vercellotti GM; Alayash AI
Blood Cells Mol Dis; 2015 Mar; 54(3):302-6. PubMed ID: 25582460
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease.
Eshbach ML; Kaur A; Rbaibi Y; Tejero J; Weisz OA
Am J Physiol Cell Physiol; 2017 Jun; 312(6):C733-C740. PubMed ID: 28356267
[TBL] [Abstract][Full Text] [Related]
3. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Quimby KR; Hambleton IR; Landis RC
Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
[TBL] [Abstract][Full Text] [Related]
4. Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function.
Shi PA; Choi E; Chintagari NR; Nguyen J; Guo X; Yazdanbakhsh K; Mohandas N; Alayash AI; Manci EA; Belcher JD; Vercellotti GM
Br J Haematol; 2016 Nov; 175(4):714-723. PubMed ID: 27507623
[TBL] [Abstract][Full Text] [Related]
5. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
6. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
Yalamanoglu A; Deuel JW; Hunt RC; Baek JH; Hassell K; Redinius K; Irwin DC; Schaer DJ; Buehler PW
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L765-L774. PubMed ID: 30047285
[TBL] [Abstract][Full Text] [Related]
7. The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging.
Thomsen JH; Etzerodt A; Svendsen P; Moestrup SK
Oxid Med Cell Longev; 2013; 2013():523652. PubMed ID: 23781295
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis.
Lim YK; Jenner A; Ali AB; Wang Y; Hsu SI; Chong SM; Baumman H; Halliwell B; Lim SK
Kidney Int; 2000 Sep; 58(3):1033-44. PubMed ID: 10972668
[TBL] [Abstract][Full Text] [Related]
9. The reaction of hydrogen peroxide with hemoglobin induces extensive alpha-globin crosslinking and impairs the interaction of hemoglobin with endogenous scavenger pathways.
Vallelian F; Pimenova T; Pereira CP; Abraham B; Mikolajczyk MG; Schoedon G; Zenobi R; Alayash AI; Buehler PW; Schaer DJ
Free Radic Biol Med; 2008 Oct; 45(8):1150-8. PubMed ID: 18708138
[TBL] [Abstract][Full Text] [Related]
10. The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin.
Ji X; Feng Y; Tian H; Meng W; Wang W; Liu N; Zhang J; Wang L; Wang J; Gao H
PLoS One; 2016; 11(10):e0164264. PubMed ID: 27716784
[TBL] [Abstract][Full Text] [Related]
11. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
Gbotosho OT; Kapetanaki MG; Kato GJ
Front Immunol; 2020; 11():561917. PubMed ID: 33584641
[TBL] [Abstract][Full Text] [Related]
12. CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system.
Schaer CA; Vallelian F; Imhof A; Schoedon G; Schaer DJ
J Leukoc Biol; 2007 Jul; 82(1):106-10. PubMed ID: 17460152
[TBL] [Abstract][Full Text] [Related]
13. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
14. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity.
Bains SK; Foresti R; Howard J; Atwal S; Green CJ; Motterlini R
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):305-12. PubMed ID: 19965783
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical studies on hemoglobin-haptoglobin and hemoglobin catabolism sites.
Kino K; Mizumoto K; Watanabe J; Tsunoo H
J Histochem Cytochem; 1987 Mar; 35(3):381-6. PubMed ID: 3546486
[TBL] [Abstract][Full Text] [Related]
16. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.
Nath KA; Grande JP; Haggard JJ; Croatt AJ; Katusic ZS; Solovey A; Hebbel RP
Am J Pathol; 2001 Mar; 158(3):893-903. PubMed ID: 11238038
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin.
Andersen CBF; Stødkilde K; Sæderup KL; Kuhlee A; Raunser S; Graversen JH; Moestrup SK
Antioxid Redox Signal; 2017 May; 26(14):814-831. PubMed ID: 27650279
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid enhances heme oxygenase-1 production by circulating monocytes by up-regulating hemoglobin scavenger receptor and amplifying the receptor-mediated uptake of hemoglobin-haptoglobin complex.
Yamazaki H; Ohta K; Tsukiji H; Toma T; Hashida Y; Ishizaki A; Saito T; Arai S; Koizumi S; Yachie A
Biochem Biophys Res Commun; 2007 Jun; 358(2):506-12. PubMed ID: 17490617
[TBL] [Abstract][Full Text] [Related]
20. HO-1
Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K
Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
